Clinical Trial: An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title:
Brief Summary: This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.
Detailed Summary:
Sponsor: Allergan
Current Primary Outcome: Percentage of Subjects Satisfied With Latisse® [ Time Frame: Day 1 ]
Original Primary Outcome: Percentage of Subjects Satisfied With Latisse® [ Time Frame: Day 1 ]
Current Secondary Outcome:
- Number of Applications of Latisse® Per Week [ Time Frame: Day 1 ]Number of applications of Latisse® per week as reported by the subjects.
- Percentage of Subjects Satisfied Wtih Their Eyelashes [ Time Frame: Day 1 ]Overall subject satisfaction with their eyelashes was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.
Original Secondary Outcome:
- Number of Applications of Latisse® Per Week [ Time Frame: Day 1 ]
- Percentage of Subjects Satisfied Wtih Their Eyelashes [ Time Frame: Day 1 ]
Information By: Allergan
Dates:
Date Received: June 18, 2012
Date Started: November 2010
Date Completion:
Last Updated: August 16, 2012
Last Verified: August 2012